<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Investment potential on FinanClub</title>
    <link>https://finan.club/tags/investment-potential/</link>
    <description>Recent content in Investment potential on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 27 Jan 2024 09:04:43 +0000</lastBuildDate><atom:link href="https://finan.club/tags/investment-potential/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>NYCB</title>
      <link>https://finan.club/us/nycb/</link>
      <pubDate>Sat, 27 Jan 2024 09:04:43 +0000</pubDate>
      
      <guid>https://finan.club/us/nycb/</guid>
      <description>score:233
Chances: New York Community Bancorp expects to issue its earnings release for the three and twelve months ended December 31, 2023 on January 31, 2024. Amid the uncertain macroeconomic backdrop, high dividend-yielding stocks like New York Community Bancorp could be attractive to investors.</description>
    </item>
    
    <item>
      <title>IBRX</title>
      <link>https://finan.club/us/ibrx/</link>
      <pubDate>Thu, 28 Dec 2023 09:05:11 +0000</pubDate>
      
      <guid>https://finan.club/us/ibrx/</guid>
      <description>score:64
Chances: ImmunityBio, Inc. is participating in the 35th Annual Piper Sandler Healthcare Conference, which is a positive sign for potential collaborations and investor interest. The new data showing the potential benefits of Memory Cytokine-Enriched Natural Killer cells (M-ceNK) for patients with small cell lung cancer and other types of neuroendocrine tumors indicates promising developments in the companyâ€™s immunotherapy platform.</description>
    </item>
    
  </channel>
</rss>
